FTC sues key pharmacy benefit administrators over insulin price ranges The company introduced action against Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist price of lifestyle-saving insulin prescription drugs. Expense in electronic health firms arrived at many years-very low levels previous https://daveshotchickennutrition39416.blogsmine.com/31112964/about-healthcare-news